Houston Methodist

Latest

Houston Methodist

·August 5, 2022·5 min read

COVID-19 Infection in Crucial Brain Regions May Lead To Accelerated Brain Aging

The effects of COVID-19 infection on neurological health are becoming more apparent. A new study reveals COVID-19 can predispose people to irreversible neurological conditions, accelerate brain aging, and increase the risk of stroke and brain bleeds.

This shows the outline of a person with the gut highlighted

Featured Neurology Neuroscience

·May 10, 2022·5 min read

Clues About Concussions From the Gut

Signs of concussion may be found in the gut, a new study reports. Researchers found a correlation between traumatic brain injury proteins in the blood and one brain injury-linked bacteria in stool samples.

Brain Cancer Featured Neurology Neuroscience Open Neuroscience Articles

·July 23, 2021·3 min read

Investigational Magnetic Device Shrinks Glioblastoma in First-in-World Human Test

A novel helmet that generates a noninvasive oscillating magnetic field was able to reduce tumor mass by 31% in a glioblastoma brain cancer patient.

This is a cartoon of a woman's head and covid

Featured Neurology Neuroscience Open Neuroscience Articles

·April 27, 2021·3 min read

Rare Neurological Condition Linked to COVID-19 Cases in 21 Countries

Researchers have identified acute transverse myelitis (ATM) in a number of COVID-19 patients. ATM, which is marked by inflammation of the spinal cord, is a rare neurological disorder that can lead to spinal cord lesions, paralysis, and bowel dysfunction.

Brain Cancer Featured Neurology

·October 9, 2020·3 min read

Experimental Glioblastoma Therapy Shows Curative Powers

MP-Pt(IV), a second generation prodrug appears to have curative properties against glioblastoma when coupled with chemotherapy in mouse models.

Featured Neuroscience

·April 16, 2020·4 min read

Investigational Remdesivir therapy gaining reputation as promising COVID-19 antiviral

Researchers conducting a clinical trial of Remdesivir to treat coronavirus report the drug appears to be promising. The drug, initially designed to treat Ebola, is well tolerated, and patients treated with the drug are showing signs of recovery. Early indications suggest Remdesivir could stave off the need for intubating patients suffering from COVID-19.

This shows a blood test tube with covid19 written on it

Featured Neuroscience

·March 30, 2020·4 min read

FDA approves Houston Methodist for COVID-19 plasma therapy

On Saturday, the FDA approved Houston Methodist to conduct transfused plasma therapy for the treatment of COVID-19. The plasma will be donated from recovered COVID-19 patients and transfused into those critically ill with the virus. Researchers have already begun recruiting donors in the Houston area who have recovered from coronavirus. The first donor was a patient in the Houston Metropolitan area who has been in good health for two weeks following COVID-19 infection.

Brain Cancer Featured Genetics Neurology Neuroscience Open Neuroscience Articles

·January 13, 2020·4 min read

Protein associated with ovarian cancer exacerbates neurodegeneration in Alzheimer’s

OCIAD1, a protein commonly associated with ovarian cancer, contributes to neurodegeneration in Alzheimer's disease by impairing mitochondrial function, leading to synaptic damage and neural vulnerability.

Featured Neuroscience Psychology

·August 7, 2019·3 min read

Four Ways Binge-Watching Hurts Your Brain

Binge-watching TV shows can create an unhealthy environment for the brain due to social isolation, sleep deprivation and unhealthy eating habits.

Featured Genetics Neurology Open Neuroscience Articles

·May 21, 2018·5 min read

Immune Cells Hold Promise For Slowing ALS Progression

A new immunotherapy treatment for ALS patients is not only safe, but can also help slow the progression of the disease, researchers report.

Brain Cancer Featured Neurology

·March 22, 2018·3 min read

Compound that Prevents Breast Cancer Cells From Activating in the Brain Identified

A compound used to treat leukemia shows promise in preventing breast cancer cells from metastasizing in the brain.

Featured Neurology Neuroscience Psychology

·December 13, 2017·3 min read

Treatable Immune System Disorder Could Be Mistaken For Schizophrenia or Bipolar Disorder

A major finding from researchers at Houston Methodist reveals a significant number of people diagnosed with schizophrenia or bipolar disorder may actually have a treatable immune system disorder. The condition causes NMDA receptors to stop functioning properly and can result in symptoms commonly associated with neuropsychiatric disorders.

1 2

Username
Password

	Remember Me Lost your password?